- DE40 in the zone of local highs
- Kering spoils sentiment in Europe
- nvestors await FOMC decision (06:00 pm GMT)
General market situation:
Wednesday's session on European markets brings a continuation of the uncertain ground of the ongoing bull market. The major benchmarks are trading mostly slightly lower on an intraday basis. The worst performing benchmark is currently the French CAC40, which is losing 0.65%. Companies in the Netherlands and Switzerland in particular are showing good momentum. Overall, the negative echo of today's session on the Old Continent is driven by cheapening fashion companies, which reacted with uncertainty to Kering's (KER.FR) earnings warning.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile app
European companies listed during Wednesday's trading session are currently trading at mixed levels. The biggest losers are the previously mentioned fashion companies. Source: xStation 5
Germany's benchmark DE40 is trading up slightly during today's session. The main control level remains at all times the historical peak near 18281 points. Source: xStation 5
News:
Deutz (DEZ.DE) is up nearly 8.3% today. The engine manufacturer's shares thus unwound volatility after the previous day's annual report. A Warburg analyst raised his target price to €10.50. According to the expert, the expected recovery in the second half of the year offers an attractive opportunity to enter the market.
Profit-taking is seen on Rheinmetall (RHM.DE) shares, which fell 2.8% during today's session. Group CEO Armin Papperger sold the company's shares for nearly five million euros after a sharp rise in recent months.
Shares of Hugo Boss (BOSS.DE), Puma (PUM.DE) and Adidas (ADS.DE) are under downward pressure today following disappointing sales forecasts from French luxury goods group Kering (KER.FR) for the current quarter.
Other news about individual companies included in the DAX index. Source: Bloomberg Financial LP
Analyst recommendations:
- Encavis (ECVDE) was cut to a ,,Hold" rating by HSBC. The target price was set at 17.50 euros.
- HSBC raised its recommendation on shares of Redcare Pharmacy NV to a rating of . "Hold". The target price at €140.
- BASF (BAS.DE) was upgraded to a ,,Buy" rating by Berenberg against signs of a resurgence in the chemical sector. Target price at 58 euros.
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
